Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CalciMedica, Inc. (GRAY) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Sanderling Venture Partners VI LP (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns: Granted 703,388 shares @ $0
Granted 582,757 shares @ $0
Granted 17,682 shares @ $0
Granted 7,456 shares @ $0
Granted 8,884 shares @ $0
Granted 240,676 shares @ $0
Granted 14,425 shares @ $0
Granted 63,228 shares @ $0
Granted 1,548 shares @ $0
Granted 2,672 warrants @ $26.74, valued at $71.4k
Granted 16,539 warrants @ $27.94, valued at $462.1k
10/10/2023 3 Sanderling Venture Partners VI LP (10% Owner) has filed a Form 3 on CalciMedica, Inc.
08/23/2023 4 Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 1,750 shares @ $3.25, valued at $5.7k
Bought 714 shares @ $3.27, valued at $2.3k
08/21/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/11/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Independent Registered Public Accounting Firm",
"Updated Business Description",
"Audited recasted financial statements of Private CalciMedica as of and for the years ended December 31, 2022 and 2021"
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates"
06/28/2023 4 WILSON ROBERT N (Director) has filed a Form 4 on CalciMedica, Inc.
Txns: Granted 20,000 options to buy @ $3.25, valued at $65k
06/28/2023 4 MIDDLETON FRED A (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns: Granted 20,000 options to buy @ $3.25, valued at $65k
06/28/2023 4 Shaw Allan (Director) has filed a Form 4 on CalciMedica, Inc.
Txns: Granted 20,000 options to buy @ $3.25, valued at $65k
06/28/2023 4 BJERKHOLT ERIC (Director) has filed a Form 4 on CalciMedica, Inc.
Txns: Granted 20,000 options to buy @ $3.25, valued at $65k
06/28/2023 ARS Form ARS - Annual Report to Security Holders:
06/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
06/15/2023 4/A Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 1,000 shares @ $5.225, valued at $5.2k
06/12/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "CalciMedica Announces Relisting on Nasdaq June 12, 2023 11:30 AM EDT LA JOLLA, Calif., June 12, 2023 - CalciMedica Inc. , a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need, today announced that The Nasdaq Stock Market LLC has approved CalciMedica's application for the relisting of the Company's common stock on the Nasdaq Capital Market. The Company's common stock is expected to commence trading on the Nasdaq Capital Market at the opening of trading on Wednesday, June 14, 2023, under the ticker symbol “CALC”. CalciMedica's common stock will continue to trade on the OTCQB until market close on the date before listing on the Nasdaq Stock Market under the ticker symbol “CALC”. “We are pleased that we are r..."
06/09/2023 4 MIDDLETON FRED A (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 714 shares @ $5.2, valued at $3.7k
06/09/2023 4 Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 485 shares @ $5.2, valued at $2.5k
06/09/2023 4 Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 928 shares @ $5.2269, valued at $4.9k
Bought 400 shares @ $5.25, valued at $2.1k
06/08/2023 4 MIDDLETON FRED A (10% Owner) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 500 shares @ $4.8808, valued at $2.4k
Bought 500 shares @ $5.2, valued at $2.6k
06/08/2023 4 Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 3,200 shares @ $5.087, valued at $16.3k
Bought 1,500 shares @ $5.2267, valued at $7.8k
06/08/2023 4 Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 1,000 shares @ $5.1287, valued at $5.1k
Bought 1,000 shares @ $5.2478, valued at $5.2k
06/05/2023 4 Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 1,000 shares @ $4.8, valued at $4.8k
06/05/2023 4/A Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 1,000 shares @ $2.698, valued at $2.7k
06/05/2023 4 Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 2,000 shares @ $4.415, valued at $8.8k
Bought 1,687 shares @ $4.9, valued at $8.3k
06/01/2023 4 Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 1,000 shares @ $4.21, valued at $4.2k
06/01/2023 4 BJERKHOLT ERIC (Director) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 5 shares @ $3.25, valued at $16.3
Bought 100 shares @ $4.0875, valued at $408.8
Bought 150 shares @ $4.2, valued at $630
06/01/2023 4 Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 2,000 shares @ $3.8616, valued at $7.7k
05/24/2023 4 BJERKHOLT ERIC (Director) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 500 shares @ $3.268, valued at $1.6k
05/24/2023 4 Leheny A. Rachel (CEO) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 3,000 shares @ $3.3439, valued at $10k
05/24/2023 4 Roberts Eric W (Chief Business Officer) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 6,000 shares @ $2.95, valued at $17.7k
Bought 2,000 shares @ $3.263, valued at $6.5k
05/23/2023 SC 13D/A Flynn James E reports a 4.9% stake in CalciMedica, Inc.
05/18/2023 4 BJERKHOLT ERIC (Director) has filed a Form 4 on CalciMedica, Inc.
Txns: Bought 800 shares @ $2.7, valued at $2.2k
Bought 200 shares @ $2.67, valued at $534
Bought 300 shares @ $2.7, valued at $810
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy